Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:monoclonal_antibody
|
| gptkbp:alternativeName |
gptkb:nirsevimab
|
| gptkbp:ATCCode |
J06BD05
|
| gptkbp:CASNumber |
1804090-72-3
|
| gptkbp:clinicalTrialPhase |
Phase 3
|
| gptkbp:developedBy |
gptkb:AstraZeneca
gptkb:MedImmune |
| https://www.w3.org/2000/01/rdf-schema#label |
MEDI8897
|
| gptkbp:indication |
prevention of respiratory syncytial virus (RSV) infection
|
| gptkbp:macromoleculeType |
IgG1 monoclonal antibody
|
| gptkbp:mechanismOfAction |
neutralizes RSV by binding to F protein
|
| gptkbp:routeOfAdministration |
intramuscular
|
| gptkbp:status |
approved in EU
under review in US |
| gptkbp:target |
gptkb:RSV_F_protein
|
| gptkbp:UNII |
6Q1K1Y1F1F
|
| gptkbp:bfsParent |
gptkb:YTE
|
| gptkbp:bfsLayer |
7
|